Dr. William T. Varnado

Claim this profile

Louisiana Hematology Oncology Associates LLC

Studies Adenocarcinoma
Studies Pancreatic Cancer
1 reported clinical trial
1 drug studied

Area of expertise

1Adenocarcinoma
William T. Varnado has run 1 trial for Adenocarcinoma. Some of their research focus areas include:
BRCA1 positive
BRCA2 positive
PALB2 positive
2Pancreatic Cancer
William T. Varnado has run 1 trial for Pancreatic Cancer. Some of their research focus areas include:
BRCA1 positive
BRCA2 positive
PALB2 positive

Affiliated Hospitals

Image of trial facility.
Louisiana Hematology Oncology Associates LLC
Image of trial facility.
Mary Bird Perkins Cancer Center

Clinical Trials William T. Varnado is currently running

Image of trial facility.

Olaparib

for Pancreatic Cancer

This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that has been surgically removed (resected) and has a pathogenic mutation in BRCA1, BRCA2, or PALB2. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy.
Recruiting0 awards Phase 232 criteria

More about William T. Varnado

Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments William T. Varnado has experience with
  • Olaparib
Breakdown of trials William T. Varnado has run
Adenocarcinoma
Pancreatic Cancer
Cancer
Adenosquamous Carcinoma
Acinar Cell Carcinoma

Other Doctors you might be interested in

Patricia Braly, MDWomen's Cancer Care
Victor T. LinUniversity of Alabama at Birmingham Cancer Center
Augusto C. OchoaLSU Health Baton Rouge-North Clinic

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William T. Varnado specialize in?
William T. Varnado focuses on Adenocarcinoma and Pancreatic Cancer. In particular, much of their work with Adenocarcinoma has involved BRCA1 positive patients, or patients who are BRCA2 positive.
Is William T. Varnado currently recruiting for clinical trials?
Yes, William T. Varnado is currently recruiting for 1 clinical trial in Baton Rouge Louisiana. If you're interested in participating, you should apply.
Are there any treatments that William T. Varnado has studied deeply?
Yes, William T. Varnado has studied treatments such as Olaparib.
What is the best way to schedule an appointment with William T. Varnado?
Apply for one of the trials that William T. Varnado is conducting.
What is the office address of William T. Varnado?
The office of William T. Varnado is located at: Louisiana Hematology Oncology Associates LLC, Baton Rouge, Louisiana 70809 United States. This is the address for their practice at the Louisiana Hematology Oncology Associates LLC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top